New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 25, 2014
08:30 EDTATRCAtriCure posted outstanding Q2 results, says Canaccord
Canaccord said Atricure posted outstanding Q2 results, citing its growth trajectory, its integration of the Estech acquisition, and its investments in education and product development. The firm feels Atricure is undervalued and reiterates its Buy rating and $26 price target on the shares.
News For ATRC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 28, 2015
16:29 EDTATRCAtriCure raises FY15 revenue to $127M-$129M from $123.5-$125.5M
Subscribe for More Information
16:28 EDTATRCAtriCure reports Q2 EPS (18c), consensus (21c)
Reports Q2 revenue $32.58M, consensus $30.51M.
09:17 EDTATRCAtriCure management to meet with Needham
Meetings to be held in Southern California on July 29-30 hosted by Needham.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use